Impact of the COVID-19 Pandemic on Cancer Screening Delays
Journal of Clinical Oncology · 10.06.2023 · 41 (17) · 3194-3202
DOI: 10.1200/jco.22.01704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.06.2023. Verfasst von Xiaochen Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Prevention and Control, Department of Internal Medicine, The Ohio State University, Columbus, OH. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, COVID-19. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
PURPOSE To examine delays in cancer screenings during the COVID-19 pandemic. METHODS Participants from previous studies (N = 32,989) with permissions to be recontacted were invited to complete a survey between June and November 2020. Participants (n = 7,115) who met the age range for cancer screenings were included. Participants were asked if they planned to have and then if they postponed a scheduled mammogram, Pap test, stool blood test, colonoscopy, or human papillomavirus (HPV) test. Logistic regression was used to determine the factors associated with cancer screening delays for each planned test. RESULTS The average age was 57.3 years, 75% were female, 89% were non-Hispanic White, 14% had public insurance, and 34% lived in rural counties. Those who planned cancer screenings (n = 4,266, 60%) were younger, more likely to be female, with higher education, had private insurance, and lived in rural counties. Specifically, 24% delayed a mammogram (n = 732/2,986), 27% delayed a Pap test (n = 448/1,651), 27% delayed an HPV test (n = 59/220), 11% delayed a stool blood test (n = 44/388), and 36% delayed a colonoscopy (n = 304/840). Age, race/ethnicity, education, and health insurance were associated with delays in cancer screenings (all P < .05). Compared with non-Hispanic White women, non-Hispanic Black women had lower odds of delaying a mammogram (odds ratio [OR], 0.60; 95% CI, 0.39 to 0.94), Hispanic women had higher odds of delaying Pap test (OR, 2.46; 95% CI, 1.34 to 4.55), and women with other race/ethnicity had higher odds of delaying both Pap test (OR, 2.38; 95% CI, 1.41 to 4.02) and HPV test (OR, 5.37; 95% CI, 1.44 to 19.97). CONCLUSION Our findings highlighted the urgency for health care providers to address the significant delays in cancer screenings in those most likely to delay. Strategies and resources are needed to help those with barriers to receiving guideline-appropriate cancer screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cancer Prevention and Control, Department of Internal Medicine, The Ohio State University, Columbus, OH.
- Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH.
- Secondary Data Core, Center for Biostatistics, College of Medicine, The Ohio State University, Columbus, OH.
ORCID-Profile: Xiaochen Zhang, Mohamed I Elsaid, Victoria L Champion, Electra D Paskett
Förderung
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Zhang, X., Elsaid, M. I., DeGraffinreid, C., Champion, V. L., Paskett, E. D., & Impact of COVID-19 on Behaviors across the Cancer Control Continuum in Ohio group (2023). Impact of the COVID-19 Pandemic on Cancer Screening Delays. Journal of Clinical Oncology, 41(17), 3194-3202. https://doi.org/10.1200/jco.22.01704
Vancouver
Zhang X, Elsaid MI, DeGraffinreid C, Champion VL, Paskett ED, Impact of COVID-19 on Behaviors across the Cancer Control Continuum in Ohio group. Impact of the COVID-19 Pandemic on Cancer Screening Delays. Journal of Clinical Oncology. 2023;41(17):3194-3202. doi:10.1200/jco.22.01704
BibTeX
@article{Zhang2023,
author = {Zhang, Xiaochen and Elsaid, Mohamed I and DeGraffinreid, Cecilia and Champion, Victoria L and Paskett, Electra D and Impact of COVID-19 on Behaviors across the Cancer Control Continuum in Ohio group, Impact of COVID-19 on Behaviors across the Cancer Control Continuum in Ohio group},
title = {Impact of the COVID-19 Pandemic on Cancer Screening Delays},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {17},
pages = {3194--3202},
doi = {10.1200/jco.22.01704}
}
EUVIMED